BRAINSTORM CELL THERAPEUTICS INC. Value Added Tax Receivable, Current
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Value Added Tax Receivable, Current of $86.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Notes › Nontrade Receivables › Nontrade Receivables, Current
us-gaap:ValueAddedTaxReceivableCurrent · last filed 2022-03-28
- 2021-12-31: Value Added Tax Receivable, Current $86.00K.
- 2020-12-31: Value Added Tax Receivable, Current $84.00K.
- 2019-12-31: Value Added Tax Receivable, Current $90.00K.
- 2018-12-31: Value Added Tax Receivable, Current $90.00K.
| Period end | Value Added Tax Receivable, Current |
|---|---|
| 2021-12-31 | $86.00K 10-K · filed 2022-03-28 |
| 2020-12-31 | $84.00K 10-K · filed 2022-03-28 |
| 2019-12-31 | $90.00K 10-K · filed 2021-02-04 |
| 2018-12-31 | $90.00K 10-K · filed 2020-02-18 |
| 2017-12-31 | $98.00K 10-K · filed 2019-04-01 |
| 2016-12-31 | $152.00K 10-K · filed 2018-03-08 |
| 2015-12-31 | $152.00K 10-K · filed 2017-03-29 |
| 2014-12-31 | $43.00K 10-K · filed 2016-03-09 |
| 2013-12-31 | $60.00K 10-K · filed 2015-03-26 |
| 2012-12-31 | $108.00K 10-K · filed 2014-03-27 |
| 2011-12-31 | $76.00K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |